Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Theratechnologies Inc (THERF)

Theratechnologies Inc (THERF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theratechnologies Inc 2015 Peel Street 5th Floor MONTREAL A8 H3A 1T8 CAN

www.theratech.com P: 514-336-7800

Description:

Theratechnologies, Inc. is a pharmaceutical company focusing on the development of therapeutic peptide products with an emphasis on growth-hormone releasing factor peptides. It's main product EGRIFTA is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy which is marketed primarily in the United States, Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, and Thailand. Theratechnologies, Inc. is headquartered in Montreal, Canada.

Key Statistics

Overview:

Market Capitalization, $K 292,421
Shares Outstanding, K 76,953
Annual Sales, $ 45,380 K
Annual Net Income, $ -4,660 K
Last Quarter Sales, $ 15,610 K
Last Quarter Net Income, $ -3,170 K
60-Month Beta 0.58
% of Institutional Shareholders 1.37%
Float, K 76,953
% Float 100.00%

Growth:

1-Year Return -44.36%
3-Year Return 51.39%
5-Year Return 826.83%
5-Year Revenue Growth 514.91%
5-Year Earnings Growth 50.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 10/08/19
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year -200.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

THERF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -14.31%
Return-on-Assets % -4.25%
Profit Margin % -10.27%
Debt/Equity 1.41
Price/Sales 6.18
Price/Cash Flow 185.37
Price/Book 9.74
Book Value/Share 0.41
Interest Coverage -0.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar